Ruella Lab
@RuellaLab
We focus on mechanisms of relapse after CAR-T therapy. Our goal is to design innovative combined IMT for relapsing/refractory Leukemia & Lymphoma. @MarcoRuella
@RuellaLab hasn’t posted
When they do, their posts will show up here.